Home » Topics » Regulatory » Patents

Patents
RSS

Azacycloalkane derivatives for diabetes and related disorders patented by Synthelabo

Feb. 26, 1999

NNRTIs from Boehringer Ingelheim effective against mutant viruses

Feb. 25, 1999

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

ICE/ced-3 cysteine protease inhibitors in development at Idun

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

New compounds from Pharmacia & Upjohn interfere in the kynurenine metabolic pathway

Feb. 25, 1999

Danish and Indian investigators disclose optically active nonsteroidal antiestrogens

Feb. 24, 1999

Purinoceptor antagonists claimed by Astra, useful for inflammatory diseases

Feb. 24, 1999

Orally active antifungal agents designed by Janssen scientists

Feb. 24, 1999

Synthelabo patents potent and selective nAChR ligands

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...